nach oben

Current Infectious Disease Reports

Erschienen in:

01.07.2010

Is There a Role for Antiplatelet Therapy in Infective Endocarditis? A Review of Current Scientific Evidence

verfasst von: Nandan S. Anavekar, Joseph G. Murphy

Erschienen in: Current Infectious Disease Reports | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Recently, interest has emerged regarding adjuvant antiplatelet therapy in infective endocarditis (IE) and its impact on clinical outcomes. Despite ongoing research, the role of antiplatelet therapy in this setting remains unclear. Generally, investigations of IE are limited by the low incidence of the disease, practical issues related to diagnosis, and the highly variable latency period between symptom onset and definitive diagnosis. This article reviews the rationale for using antiplatelet therapy in the setting of IE and the contemporary literature that investigates its use.

Steckelberg JM, Murphy JG, Ballard D, et al.: Emboli in infective endocarditis: the prognostic value of echocardiography. Ann Intern Med 1991, 114:635–640.PubMed

• Tleyjeh IM, Steckelberg JM, Murad HS, et al.: Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA 2005, 293:3022–3028. This article delineates the epidemiology of IE in a homogenous populations, providing validity of outcome measures.CrossRefPubMed

Baddour LM, Wilson WR, Baye AS, et al.: Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005, 111:e394–e434.CrossRefPubMed

Delahaye JP, Poncet P, Malquarti V, et al.: Cerebrovascular accidents in infective endocarditis: role of anticoagulation. Eur Heart J 1990, 11:1074–1078.PubMed

Heiro M, Nikoskelainen J, Engblom E, et al.: Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland. Arch Intern Med 2000, 160:2781–2787.CrossRefPubMed

Sanfilippo AJ, Picard MH, Newell JB, et al.: Echocardiographic assessment of patients with infectious endocarditis: prediction of risk for complications. J Am Coll Cardiol 1991, 18:1191–1199.CrossRefPubMed

• Anavekar NS, Tleyjeh IM, Anavekar NS, et al.: Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis. Clin Infect Dis 2007, 44:1180–1186. This article is a retrospective study that demonstrates a benefit of prior antiplatelet therapy on outcomes in patients with infective endocarditis.CrossRefPubMed

Chan KL, Dumesnil JG, Cujec B, et al.: A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol 2003, 42:775–780.CrossRefPubMed

• Chan KL, Tam J, Dumesnil JG, et al.: Effect of long-term aspirin use on embolic events in infective endocarditis. Clin Infect Dis 2008, 46:37–41. This article describes the only major randomized controlled trial in infective endocarditis that was designed to assess utility of aspirin therapy.CrossRefPubMed

10.

• Sedlacek M, Gemery JM, Cheung AL, et al.: Aspirin treatment is associated with a significantly decreased risk of Staphylococcus aureus bacteremia in hemodialysis patients with tunneled catheters. Am J Kidney Dis 2007, 49:401–408. This article provides clinical evidence for antimicrobial activity of aspirin in the setting of S. aureus bacteremia.CrossRefPubMed

11.

Kupferwasser LI, Yeaman MR, Nast CC, et al.: Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus. J Clin Invest 2003, 112:222–233.PubMed

12.

Kupferwasser LI, Yeaman MR, Shapiro SM, et al.: Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects. Circulation 1999, 99:2791–2797.PubMed

13.

Nicolau DP, Freeman CD, Nightingale CH, et al.: Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis. Infect Immun 1993, 61:1593–1595.PubMed

14.

Nicolau DP, Marangos MN, Nightingale CH, Quintiliani R: Influence of aspirin on development and treatment of experimental Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 1995, 39:1748–1751.PubMed

15.

Nicolau DP, Tessier PR, Nightingale CH: Beneficial effect of combination antiplatelet therapy on the development of experimental Staphylococcus aureus endocarditis. Int J Antimicrob Agents 1999, 11:159–161.CrossRefPubMed

16.

Nicolau DP, Tessier PR, Nightingale CH, Quintiliani R: Influence of adjunctive ticlopidine on the treatment of experimental Staphylococcus aureus endocarditis. Int J Antimicrob Agents 1998, 9:227–229.CrossRefPubMed

17.

Durack DT, Beeson PB: Experimental bacterial endocarditis. I. Colonization of a sterile vegetation. Br J Exp Pathol 1972, 53:44–49.PubMed

18.

Domenico P, Schwartz S, Cunha BA: Reduction of capsular polysaccharide production in Klebsiella pneumoniae by sodium salicylate. Infect Immun 1989, 57:3778–3782.PubMed

19.

Farber BF, Wolff AG: The use of nonsteroidal antiinflammatory drugs to prevent adherence of Staphylococcus epidermidis to medical polymers. J Infect Dis 1992, 166:861–865.PubMed

20.

Kurth T, Glynn RJ, Walker AM, et al.: Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs. Circulation 2003, 108:1191–1195.CrossRefPubMed

21.

Polonio RE, Mermel LA, Paquette GE, Sperry JF: Eradication of biofilm-forming Staphylococcus epidermidis (RP62A) by a combination of sodium salicylate and vancomycin. Antimicrob Agents Chemother 2001, 45:3262–3266.CrossRefPubMed

22.

Taha TH, Durrant SS, Mazeika PK, et al.: Aspirin to prevent growth of vegetations and cerebral emboli in infective endocarditis. J Intern Med 1992, 231:543–546.CrossRefPubMed

23.

Eisen DP, Corey GR, McBryde ES, et al.: Reduced valve replacement surgery and complication rate in Staphylococcus aureus endocarditis patients receiving acetyl-salicylic acid. J Infect 2009, 58:332–338.CrossRefPubMed

24.

Kessler M, Hoen B, Mayeux D, et al.: Bacteremia in patients on chronic hemodialysis. A multicenter prospective survey. Nephron 1993, 64:95–100.CrossRefPubMed

Titel: Is There a Role for Antiplatelet Therapy in Infective Endocarditis? A Review of Current Scientific Evidence
verfasst von: Nandan S. Anavekar
Joseph G. Murphy
Publikationsdatum: 01.07.2010
Verlag: Current Science Inc.
Erschienen in: Current Infectious Disease Reports / Ausgabe 4/2010
Print ISSN: 1523-3847
Elektronische ISSN: 1534-3146
DOI: https://doi.org/10.1007/s11908-010-0115-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2010

Modulation of Brain Injury as a Target of Adjunctive Therapy in Bacterial Meningitis

Mycoplasma pneumoniae: Innocent Bystander or a True Cause of Central Nervous System Disease?

Clinical Trial Report: Is It Safe to Continue Anticoagulation Therapy in Patients with Infective Endocarditis?

Treatment of Drug-resistant Pneumococcal Meningitis

Approach to the Diagnosis and Management of Tuberculous Meningitis

Mycobacterial Prosthetic Valve Endocarditis